MPS Limited Appoints Ms. Deepti Singh as Chief People Officer

MPS Limited has announced the appointment of Ms. Deepti Singh as Chief People Officer and Senior Management Personnel, effective from the commencement of business hours on 23 March 2026. The company disclosed this appointment under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Key Appointment Details

The appointment details are structured as follows:

Parameter:	Details
Position:	Chief People Officer and Senior Management Personnel
Effective Date:	23 March 2026
Regulatory Compliance:	SEBI Regulation 30 disclosure
Director Relationships:	Not related to any Director of the Company

Professional Background and Experience

Ms. Deepti Singh brings over 16 years of global human resources leadership experience, having driven people strategies for high-growth technology organizations across India and North America. Her career demonstrates a proven track record of aligning people strategy with business priorities to build high-performance cultures and lead large-scale organizational transformations.

Most recently, Singh served as SVP, HR and Chief of Staff at Incedo Inc., where she operated at the intersection of strategic execution and talent scaling. In this role, she partnered with executive leadership to navigate multiple phases of global organizational evolution. Her previous experience includes pivotal roles at Flipkart during its primary era of scale, where she served as Chief of Staff to both the Chief People Officer and the Chief Operating Officer. She began her professional career at Target India.

Educational Qualifications and Expertise

Singh holds a Bachelor of Technology in Genetic Engineering and a PGDM in Human Resources and Industrial Relations. Her expertise spans multiple critical areas:

Change management and consensus building
Leadership development and talent succession planning
Strategy to execution frameworks
Employee engagement and internal communications
Employer branding initiatives

Strategic Mandate at MPS Limited

In her capacity as Chief People Officer, Ms. Deepti Singh will be responsible for leading the global people strategy to strengthen organizational capability and instill a culture of surgical efficiency and high performance. Her strategic focus areas include:

Focus Area:	Description
High-Performance Culture:	Driving accountability and excellence aligned with industry-leading EBITDA margins
Value Engineering:	Applying lean, efficiency-driven approach to organizational design and talent acquisition
Leadership Collaboration:	Strengthening professional environment through physical presence and high-touch engagement
Integration Management:	Leading people-side integration for acquisitions including entities like Unbound Medicine
Talent Density:	Scaling global talent pool with focus on technical and leadership excellence

The appointment reflects MPS Limited's commitment to strengthening its human capital strategy as the company expands into healthcare knowledge markets and other high-growth sectors. Singh's extensive experience in scaling organizations and driving transformational change positions her to support the company's strategic objectives through enhanced organizational capability and culture development.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+0.40%	-1.74%	+2.29%	-31.64%	-44.69%	+245.17%

MPS Pharmaa Limited has announced the scheduling of a separate meeting of Independent Directors in compliance with regulatory requirements. The pharmaceutical company, formerly known as Advik Laboratories Limited, issued the notice on March 16, 2026, informing stock exchanges about this important governance meeting.

Meeting Details and Regulatory Compliance

The Independent Directors meeting has been scheduled under the provisions of Regulation 25(3) of the Securities and Exchange Board of India (LODR) Regulations, 2015, and Schedule IV of the Companies Act, 2013. The meeting will be held on Wednesday, March 25, 2026, at 11:00 A.M. at the company's corporate office located at 703, Arunachal Building, 19, Barakhamba Road, Connaught Place, New Delhi-110001.

Meeting Parameter:	Details
Date:	March 25, 2026
Time:	11:00 A.M.
Venue:	Corporate Office, New Delhi
Regulatory Framework:	SEBI LODR Regulation 25(3) & Companies Act 2013

Agenda Items for Discussion

The Independent Directors will convene to address two critical governance matters during their separate meeting:

Review the performance of non-Independent Directors and the Board as a whole
Assess the quality, quantity, and timeliness of information flow between company management and the Board

These agenda items are designed to ensure that the Board can effectively and reasonably perform their duties in the best interests of shareholders and stakeholders.

Corporate Information

MPS Pharmaa Limited operates under CIN No. L74899HR1994PLC038300 and maintains its corporate office in New Delhi while its registered office and factory are located at 138, Roz-Ka-Meo Industrial Area, Sohna, Haryana. The company secretary Pooja Chuni signed the notice digitally on March 16, 2026, ensuring proper documentation and compliance with regulatory requirements.

Stock Exchange Notification

The company has duly informed both BSE Limited and Ahmedabad Stock Exchange Limited about the scheduled meeting. This notification ensures transparency and keeps all stakeholders informed about the company's governance activities as required under listing regulations.